Lika Apriani

Lika Apriani

Universitas Padjadjaran Bandung - Sumedang / Indonesia
Medical and Health Sciences / Epidemiology and Public Health
AD Scientific Index ID: 472608
Padjadjaran University
person_outline Lika Apriani's MOST POPULAR ARTICLES
1-) Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trialR Ruslami, AR Ganiem, S Dian, L Apriani, TH Achmad, AJ van der Ven, ...The Lancet infectious diseases 13 (1), 27-35, 20133462013
2-) Four months of rifampin or nine months of isoniazid for latent tuberculosis in adultsD Menzies, M Adjobimey, R Ruslami, A Trajman, O Sow, H Kim, ...New England Journal of Medicine 379 (5), 440-453, 20182932018
3-) Safety and side effects of rifampin versus isoniazid in childrenT Diallo, M Adjobimey, R Ruslami, A Trajman, O Sow, J Obeng Baah, ...New England Journal of Medicine 379 (5), 454-463, 20181332018
4-) Mycobacterium tuberculosis Beijing genotype is an independent risk factor for tuberculosis treatment failure in IndonesiaI Parwati, B Alisjahbana, L Apriani, RD Soetikno, TH Ottenhoff, ...The Journal of infectious diseases 201 (4), 553-557, 20101162010
5-) Latent tuberculosis infection in healthcare workers in low-and middle-income countries: an updated systematic reviewL Apriani, S McAllister, K Sharples, B Alisjahbana, R Ruslami, PC Hill, ...European Respiratory Journal 53 (4), 2019892019